Skip to main content

Table 1 Clinical and demographic characteristics of dyslipidemic patients and controls at baseline

From: Simvastatin down-regulates the production of Interleukin-8 by neutrophil leukocytes from dyslipidemic patients

 

Dyslipidemic patients (n = 15)

Controls (n = 15)

P

Age (years)

57 ± 11

53 ± 13

ns

Female (n, %)

8 (53%)

4 (27%)

ns

BMI (kg/m2)

26 ± 2

26 ± 2

ns

SBP/DBP (mmHg)

135 ± 14/83 ± 7

122 ± 35/83 ± 8

ns

10 years-cardiovascular risk (%)

9.5 ± 2.1

3.3 ± 1.8

0.01

  1. BMI: body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure.
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us